Related Experiment Video
Updated: Apr 17, 2026

08:28
Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
Published on: May 9, 2025
879
Dynamic changes in serum HER2-peptide-specific autoantibodies predict response to neoadjuvant therapy in
Tatsuya Yoshida1,2, Feifei Wei3,4, Taku Kouro3,4
1Department of Breast Surgery, Saiseikai Yokohamashi Nanbu Hospital, Yokohama, Kanagawa, Japan.
Breast Cancer Research : BCR
|April 16, 2026
Abstract
No abstract available in PubMed .
Keywords:
AutoantibodyBreast cancerElastic net regressionHER-2HER2-peptideHumoral immune responseMachine learningNeoadjuvant chemotherapyPathological complete responseMore Related Videos
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
4.2K
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
17.2K